Protocol for a systematic review: association between airborne pollen, intermittent allergic rhinitis and blood pressure

Open data API in a single place

Provided by Zenodo

Get early access to Protocol for a systematic review: association between airborne pollen, intermittent allergic rhinitis and blood pressure API!

Let us know and we will figure it out for you.

Dataset information

Country of origin
Updated
2024.07.12 00:00
Created
2023.05.03
Available languages
English
Keywords
Allergic rhinitis, Allergy, Blood pressure, Hypertension, Pollen, Systematic review
Quality scoring

Dataset description

Previous epidemiological studies have found an increased risk of cardiovascular morbidity and mortality following days with heightened pollen exposure and suggested that intermittent allergic rhinitis might be associated with blood pressure. Pollen sensitization and subsequent pollen exposure cause local inflammation and cytokine release in individuals with intermittent allergic rhinitis (pollen allergy). Inflammatory mediators can travel throughout the body, hence providing the physiologic basis by which pollen allergy may lead to systemic inflammation, which is known to be a risk factor for cardiovascular events. However, the findings regarding the potential association between intermittent allergic rhinitis, pollen exposure, and cardiovascular health are not fully conclusive. To date, no systematic review has been published on this topic. This systematic review seeks to answer: Are exposure to airborne pollen and intermittent allergic rhinitis associated with blood pressure? Secondary questions include: (1) Are there personal characteristics (sex, age) which modify a potential association between intermittent allergic rhinitis or pollen exposure with blood pressure and/or hypertension? (2) What research gaps exist in our understanding of how intermittent allergic rhinitis, pollen exposure, and cardiovascular health are interrelated? Published herein are: Protocol for the systematic review, including the search strategy Supplement 1: PROSPERO registration Supplement 2: Data extraction table Supplement 3: Risk of bias assessment strategy Supplement 4: Risk of bias assessment tool
European data infrastructure with broad catalog discovery, free evaluation access and production-grade API options.
190K+
indexed dataset pages
32
countries and EU institutions
2019
API-first since
Free API quota
for evaluation and prototypes
SLA
history and push on production APIs
FAQ

Questions before production use

Practical answers on evaluation, licensing, freshness, versioning and support.

api.store is built and operated by Apitalks s.r.o. Company details and a direct contact path are linked in the footer for vendor checks and procurement review.
Yes. Selected APIs include a free API quota, so your team can validate coverage, freshness, response shape and workflow fit before asking for a production plan.
Often yes, but usage rights depend on the source license and dataset. We surface source, license and update metadata where available, and can help review terms before a production integration.
Maintained APIs include update metadata where available. For production integrations, we can add history, monitoring and push updates so changes are easier to detect and act on.
Production APIs can add SLA, stable identifiers, versioning support, history, push updates and direct support around the data your product or AI workflow depends on.

Didn't find the API you need?

Let us know and we will figure it out for you.

European data discovery with free evaluation access and production-grade API options.

Copyright © 2026. Made by Apitalks